Table 4.

Change from baseline (90% confidence interval) in the absence of a change in RR (RR0) estimated from the regression line from change from baseline in QTc versus change from baseline in RR interval for each correction method by treatment.

Treatment	QTcF (ms)	QTcB (ms)	QTcSS (ms)
DHA-PQP	21.1 (18.8, 23.4)	21.3 (19.0, 23.7)	21.1 (18.7, 23.4)
PA	2.7 (0.5, 4.8)	1.6 (−0.7, 3.8)	1.5 (−0.7, 3.7)
ASAQ	23.0 (19.6, 26.3)	23.0 (19.5, 26.5)	23.0 (19.5, 26.5)
AL	11.7 (8.7, 14.7)	11.2 (8.0, 14.3)	11.0 (7.9, 14.1)

DHA-PQP, dihydroartemisinin-piperaquine; PA, pyronaridine-artesunate; ASAQ, artesunate-amodiaquine; AL, artemether-lumefantrine.